Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Read

Showing results (711-720 of 718) with videos related to

Pageof 72
Sort By:
You have reached the last page of results.This site can display upto 718 results.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Journal of Medicinal Chemistry|December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral LeishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Nature|May 2, 2003
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaTimothy D Read, Scott N Peterson, Nicolas Tourasse, et al.
Nature|June 10, 2016
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Nature|April 25, 2003
The genome sequence of the filamentous fungus Neurospora crassaJames E Galagan, Sarah E Calvo, Katherine A Borkovich, et al.
Journal of Medicinal Chemistry|June 2, 2026
Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria ParasitesBarbara Forte, Fiona Bellany, Peter S Campbell, et al.
Nature|June 19, 2015
A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 72

Showing results (711-720 of 718) with videos related to

Sort By:
Pageof 72
You have reached the last page of results.This site can display upto 718 results.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2019
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibitionSusan Wyllie, Stephen Brand, Michael Thomas, et al.
Journal of Medicinal Chemistry|December 21, 2018
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral LeishmaniasisMichael G Thomas, Manu De Rycker, Myriam Ajakane, et al.
Nature|May 2, 2003
The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteriaTimothy D Read, Scott N Peterson, Nicolas Tourasse, et al.
Nature|June 10, 2016
Corrigendum: A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Nature|April 25, 2003
The genome sequence of the filamentous fungus Neurospora crassaJames E Galagan, Sarah E Calvo, Katherine A Borkovich, et al.
Journal of Medicinal Chemistry|June 2, 2026
Structure-Guided Optimization of Novel Inhibitors of <i>Plasmodium</i> Lysyl-tRNA Synthetase with Multistage Activity against Malaria ParasitesBarbara Forte, Fiona Bellany, Peter S Campbell, et al.
Nature|June 19, 2015
A novel multiple-stage antimalarial agent that inhibits protein synthesisBeatriz Baragaña, Irene Hallyburton, Marcus C S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2019
Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosisBeatriz Baragaña, Barbara Forte, Ryan Choi, et al.
Pageof 72